goldman sachs downgrades dr lal pathlabs & metropolis healthcare to sell, slashes target price
Published 9 months ago • 416 plays • Length 1:24
Download video MP4
Download video MP3
Similar videos
-
2:30
dr lal path labs q2 pat declines 25% to ₹72.4 crore, metropolis healthcare's profit falls in q2
-
2:07
kotak instl eq upgrades dr lal pathlabs to add from sell, metropolis healthcare's fair value raised
-
6:27
not witnessing any fall in growth rates: metropolis healthcare | cnbc tv18
-
0:36
ai could grow gdp by 1.5% over the next decade: goldman sachs
-
3:46
goldman's peter oppenheimer: this correction is healthy and somewhat inevitable but may not be over
-
11:19
key stocks in focus: lupin, tata power, fortis healthcare, gland pharma, cummins india, bata india
-
0:36
final trades: goldman sachs, devon energy, apollo global and the indy
-
5:44
dcla's sarat sethi on market sell-off: find high-quality companies if you're a long-term investor
-
10:25
ex-trump official on why trump campaign 'shouldn't get too confident' with walz
-
8:30
from aoc to manchin: how walz is uniting unexpected lawmakers
-
2:45
walz calls trump, vance 'creepy' and 'weird as hell'
-
2:42
markets seeing 'somewhat healthy' correction, goldman sachs says
-
0:37
google loses doj antitrust lawsuit over search
-
4:41
the growth and evolution of goldman sachs
-
0:54
greater kuala lumpur's population to exceed 8.8mil
-
2:15
goldman sachs to pay us$3 billion over 1mdb scandal
-
8:09
doj's kanter on google antitrust ruling: we're interested in ensuring the competitive market works
-
6:26
mdf volume growth at 40% & value growth is limited to 25%: century plyboards | cnbc tv18
-
2:44
goldman sachs says it expects japan to remove yield curve control in april 2024
-
10:26
stock market live: diagnostics stocks back in limelight amid covid fears can the momentum sustain?
-
4:41
fmr. goldman sachs asset management chairman on digital transformation
-
2:14
western digital upgraded to buy at goldman sachs
Clip.africa.com - Privacy-policy